Supplementary table 4 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma

Autor:	Martin D. McCarter, William A. Robinson, Ross W. McFarland, Rene Gonzalez, Karl D. Lewis, Theresa M. Medina, Eduardo Davila, Dexiang Gao, Kimberly R. Jordan, Kasey L. Couts, Elizabeth Katsnelson, Robert J. Van Gulick, Jessica S.W. Borgers, Dana M. Davis, Victoria M. Cates, Dasha T. Cogswell, Richard P. Tobin
Rok vydání:	2023
Popis:	Characteristics of patients experiencing clinical benefit
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616d4ce76fe5b82e2a0eb0067a364b89 https://doi.org/10.1158/1078-0432.22494979.v1 Zobrazit plný text záznamu